Online Report Evolving in Challenging Times: Siegfried Rises to the Next Level
Intro
Letter to the Shareholders
Intro
Letter to the Shareholders

Highlights of the reporting year

Siegfried_Isabelle-Welton_News.jpg

Isabelle Welton is elected to the Board of Directors.

Highlights of the reporting year

Commissioning of a 60bar hydrogenation plant in Zofingen.

Siegfried_Inbetriebnahme-einer-60bar-Hydrieranlage-in-Zofingen1.jpg

Highlights of the reporting year

Siegfried_Einweihung-eines-neuen-QC-Labors-in-St.-Vulbas.jpg

Inauguration of a new QC laboratory in St. Vulbas.

Highlights of the reporting year

Announcement of retirement of René Imwinkelried (Chief Operating Officer) and entry of Irene Wosgien as Chief Operating Officer Drug Substances into the Executive Committee as of 31.12.20

Siegfried_Ruhestand-Rene-Imwinkelried-Eintritt-von-Irene-Wosgien-in-die-Geschaeftsleitung.jpg

Highlights of the reporting year

Siegfried_Inbetriebnahme-einer-3-Verpackungslinie-in-Malta.jpg

Commissioning of a 3rd packaging line in Malta.

Highlights of the reporting year

Announcement of the acquisition of two pharmaceutical production sites in Spain.

Siegfried_pharmazeutischen-Produktionsstätten-in-Spanien-El-Masnou.jpg
Siegfried_pharmazeutischen-Produktionsstätten-in-Spanien-Barbera.jpg

Highlights of the reporting year

Siegfried-und-BioNTech-News.jpg

Siegfried and BioNTech sign contract for aseptic filling of COVID vaccine.